# Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery

> **NCT03270033** · PHASE4 · COMPLETED · sponsor: **University of Manitoba** · enrollment: 198 (actual)

## Conditions studied

- Pain, Postoperative
- Shoulder Joint Disorder
- Ambulatory Surgical Procedures
- Brachial Plexus Block

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Dexmedetomidine

## Key facts

- **NCT ID:** NCT03270033
- **Lead sponsor:** University of Manitoba
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-18
- **Primary completion:** 2018-04-14
- **Final completion:** 2018-10-13
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2019-04-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03270033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03270033, "Intravenous Dexmedetomidine, Dexamethasone and Interscalene Block Duration After Arthroscopic Shoulder Surgery". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03270033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*